Lung perfusion assessed by SPECT/CT after a minimum of three months anticoagulation therapy in patients with SARS-CoV-2-associated acute pulmonary embolism: a retrospective observational study

BACKGROUND: Anticoagulant treatment is recommended for at least three months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related acute pulmonary embolism (PE), but the persistent pulmonary clot burden after that time is unknown. METHODS: Lung perfusion was assessed by ventilat...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghaus, Thomas M., Bader, Stefanie, Faul, Christian, Haberl, Sabine, Schwarz, Florian, Liebich, Alessandro, Dierks, Alexander, Kircher, Malte, Lapa, Constantin, Pfob, Christian H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620596/
https://www.ncbi.nlm.nih.gov/pubmed/36316693
http://dx.doi.org/10.1186/s12931-022-02188-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620596/
https://www.ncbi.nlm.nih.gov/pubmed/36316693
http://dx.doi.org/10.1186/s12931-022-02188-2

Ejemplares similares